CORONA Remedies Ltd

NSE: CORONA | BSE: 544644

₹2,022.80

up-down-arrow43.40 (2.19%)

As on 09-Jul-2026IST

Market cap

info icon

₹12,348 Cr

Revenue (TTM)

info icon

₹1,403 Cr

P/E Ratio

info icon

66.7

P/B Ratio

info icon

16.5

Div. Yield

info icon

0.5 %

Value Research Rating

Quality Score fund-quick-summary-circle

Quality Score8/10

Growth Score fund-quick-summary-circle

Growth Score7/10

Valuation Score fund-quick-summary-circle

Valuation Score1/10

Momentum Score fund-quick-summary-circle

Momentum Score10/10

CORONA Remedies Share Price

Compare

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 1,984.90 High: 2,046.10

52 Week Range

Low: 1,336.60 High: 2,100.70

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹185 Cr

  • ROEROE information

    27.4 %

  • ROCEROCE information

    31.7 %

  • Industry P/EIndustry P/E information

    36.64

  • EV/EBITDAEV/EBITDA information

    40.9

  • Debt to EquityDebt to Equity information

    0.2

  • Book ValueBook Value information

    ₹122.1

  • EPSEPS information

    ₹30.3

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    61,160,088

6 Years Aggregate

CFO

₹622.78 Cr

EBITDA

₹939.34 Cr

Net Profit

₹579.53 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
CORONA Remedies
46.1 16.2 30.1 -- -- -- --
BSE Healthcare
14.7 6.3 18.3 11.9 24.3 14.1 12.0
As on 09-Jul-2026
The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
CORONA Remedies
2,022.8 12,347.9 1,403.2 185.1 -- 27.4 66.7 16.5
8,114.5 20,278.4 2,275.6 187.5 10.3 22.9 108.1 23.2
2,621.4 19,918.1 2,187.2 649.7 31.5 19 31.1 5.6
1,430.0 19,836.1 3,129.4 647.4 26.9 18.1 32 5.1
2,444.5 39,191.6 4,147.8 709.5 22.3 19.1 55.2 9.4
4,590.1 21,046.2 2,519.7 722.4 33.6 17.2 29.1 5.0
6,612.0 10,992.1 1,408.0 326.9 30.8 57.1 33.6 21.0
3,356.0 7,727.8 1,773.8 309.8 24.0 43.1 24.9 9.9
622.3 12,147.6 1,538.1 226.2 20.4 9 49.9 4.7
1,076.0 9,898.0 4,858.7 574.1 14.9 19.7 17.8 3.2

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

About CORONA Remedies

--

  • Incorporated

    2004

  • Chairman

    Kirti Mehta

  • Managing Director

    Nirav Mehta

  • Headquarters

    Ahmedabad, Gujarat

  • Website

    www.coronaremedies.com

Edit peer-selector-edit

FAQs for CORONA Remedies

The share price of CORONA Remedies Ltd is ₹2,022.80 (NSE) and ₹2,018.95 (BSE) as of 09-Jul-2026 IST. CORONA Remedies Ltd has given a return of --% in the last 1 years.

The P/E ratio of CORONA Remedies Ltd is 66.70 times as on 09-Jul-2026, a 82 premium to its peers’ median range of 36.64 times.
The P/B ratio of CORONA Remedies Ltd is 16.53 times as on 09-Jul-2026, a 201 premium to its peers’ median range of 5.49 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2026
51.41
12.74
2025
0.00
0.00
2024
0.00
0.00
2023
0.00
0.00
2022
0.00
0.00

The 52-week high and low of CORONA Remedies Ltd are Rs 2,100.70 and Rs 1,336.60 as of 10-Jul-2026.

CORONA Remedies Ltd has a market capitalisation of ₹ 12,348 Cr as on 09-Jul-2026. As per SEBI classification, it is a Small Cap company.

Before investing in CORONA Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.